info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > HER2
HER2
Cat.No. Product Name Information Area
T6712 Tyrphostin AG 879 Tyrphostin AG 879 potently inhibits HER2/ErbB2 with IC50 of 1 μM, 100- and 500-fold h... Cancer
T2501 Canertinib dihydrochloride Canertinib Dihydrochloride is the hydrochloride salt of an orally bio-available quina... Cancer
T6235 Lapatinib (GW-572016) Ditosylate Lapatinib Ditosylate (GW572016, GW2016) is a potent EGFR and ErbB2 inhibitor with IC5... Cancer
T6124 Mubritinib (TAK 165)new Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM; no activi... Cancer
T6092 AZD8931 (Sapitinib) AZD8931 is a reversible, ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 with IC50... Cancer
T6046 CP-724714 CP-724,714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM, >640-fo... Cancer
T2630 Poziotinib Poziotinib(NOV120101; HM781-36B) is an irreversible Pan-HER inhibitor with IC50s of 3... Cancer
T2610 BMS-599626 AC480 (BMS-599626) is a selective and efficacious inhibitor of HER1 and HER2 with IC5... Cancer
T2600 AG-490 AG-490 (Tyrphostin AG 490) is an inhibitor of EGFR with IC50 of 0.1 μM, 135-fold more... Other
T2518 ARRY-380 ARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent again... Cancer
T2483 Dacomitinib (PF299804, PF299) Dacomitinib(PF299804; PF-00299804) is a potent, orally available, irreversible tyrosi... Cancer
T2364 Irbinitinib Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC50 of ... Cancer
T2327 Pelitinib Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM. Pha... Cancer
T2325 Neratinib Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor wi... Cancer
T2116 AEE788 AEE788 (NVP-AEE788) is a potent inhibitor of EGFR and HER2/ErbB2 with IC50 of 2 nM an... Cancer
T2047 AG-1478 AG-1478 (Tyrphostin AG-1478) is a selective EGFR inhibitor with IC50 of 3 nM in cell-... Cancer
T1773 Afatinib (BIBW2992) Dimaleate Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), ... Cancer
T0078L Lapatinib ditosylate monohydrate Lapatinib ditosylate is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a t... Cancer
T0078 Lapatinib Lapatinib(GW-572016) is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 n... Cancer
1